{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:48:08Z","timestamp":1789001288202,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background and Purpose:<\/jats:bold> Although elevated serum lipoprotein (a) [Lp(a)] is considered to be a risk factor of ischemic stroke, the relationship between Lp(a) and cognitive impairment after stroke remains unclear. This study investigated the association between serum Lp(a) and cognitive function after acute ischemic stroke (AIS) or transient ischemic attack (TIA).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The study included 1,017 patients diagnosed with AIS or TIA from the cognition subgroup of the Third China National Stroke Registry (CNSR3). Montreal Cognitive Assessment (MoCA) at 2 weeks or discharge, 3 months, and 1 year was evaluated. The primary outcome was cognitive impairment at 1 year, defined as MoCA \u2264 22. The secondary outcome was cognition improvement at 1 year compared with 2 weeks. The association between Lp(a) levels and cognitive function was analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among the 1,017 patients included, 326 (32.1%) had cognitive impairment at 1 year. Patients with MoCA \u2264 22 at 1 year were older, received less education, and had higher baseline NIHSS, higher proportion of ischemic stroke history, large artery atherosclerosis (LAA) subtype, and multiple infarctions (<jats:italic>P<\/jats:italic> &amp;lt; 0.05 for all). Patients with highest Lp(a) quartile had slightly higher percentage of cognitive impairment at 1 year but without statistical difference. In subgroup analysis of LAA subtype, the patients with highest Lp(a) quartile had higher percentage of cognitive impairment at 1 year (adjusted OR:2.63; 95% CI: 1.05\u20136.61, <jats:italic>P<\/jats:italic> &amp;lt; 0.05). What is more, the patients with highest Lp(a) quartile in LAA subtype had lower percentage of cognition improvement at 1 year. However, similar results were not found in small artery occlusion (SAO) subtype.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Higher Lp(a) level was associated with cognitive impairment and less improvement of cognition in patients after AIS or TIA with large-artery atherosclerosis subtype.<\/jats:p>","DOI":"10.3389\/fneur.2021.736365","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T04:57:45Z","timestamp":1638507465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2257","DOI":"10.1212\/WNL.0000000000008612","article-title":"Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups","volume":"93","author":"Lo","year":"2019","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","article-title":"Preventing dementia by preventing stroke: the Berlin Manifesto","volume":"15","author":"Hachinski","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1161\/STROKEAHA.119.028587","article-title":"Network efficiency mediates the relationship between vascular burden and cognitive impairment: a diffusion tensor imaging study in UK biobank","volume":"51","author":"Shen","year":"2020","journal-title":"Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.04.005","article-title":"Biology, pathophysiology and current therapies that affect lipoprotein (a) levels","volume":"131","author":"Rawther","year":"2019","journal-title":"J Mol Cell Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10636","DOI":"10.1038\/s41598-020-66783-3","article-title":"Relationship between Lipoprotein (a) and cognitive function - results from the Berlin Aging Study II","volume":"10","author":"R\u00f6hr","year":"2020","journal-title":"Sci Rep."},{"key":"B9","first-page":"57","article-title":"Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia","volume":"4","author":"Ray","year":"2013","journal-title":"Aging Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1055\/s-0039-1687907","article-title":"Vascular disease and dementia: lipoprotein(a) as a neglected link","volume":"45","author":"Lippi","year":"2019","journal-title":"Semin Thromb Hemost."},{"key":"B11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2004.12.015","article-title":"Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"180","author":"Gaw","year":"2005","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1161\/01.STR.32.7.1678","article-title":"Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data","volume":"32","author":"Sarti","year":"2001","journal-title":"Stroke"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2580","DOI":"10.1212\/WNL.0000000000007574","article-title":"ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change","volume":"92","author":"Pokharel","year":"2019","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1161\/STROKEAHA.119.026872","article-title":"Causal effect of Lp(a) [Lipoprotein(a)] level on ischemic stroke and Alzheimer disease: a mendelian randomization study","volume":"50","author":"Pan","year":"2019","journal-title":"Stroke"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10654-016-0184-0","article-title":"Is lipoprotein (a) protective of dementia?","volume":"31","author":"Kunutsor","year":"2016","journal-title":"Eur J Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/svn-2019-000242","article-title":"The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics","volume":"4","author":"Wang","year":"2019","journal-title":"Stroke Vasc Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/svn-2020-000359","article-title":"Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry","volume":"6","author":"Wang","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.jacc.2016.10.033","article-title":"phenotypic characterization of genetically lowered human lipoprotein(a) levels","volume":"68","author":"Emdin","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000017226","article-title":"Lipoprotein(a) phenotypes in patients with vascular dementia","volume":"11","author":"Urakami","year":"2000","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000079200","article-title":"Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia","volume":"18","author":"Emanuele","year":"2004","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.2174\/1381612822666160510124801","article-title":"Inflammation, endothelial dysfunction and arterial stiffness as therapeutic targets in cardiovascular medicine","volume":"22","author":"Della Corte","year":"2016","journal-title":"Curr Pharm Design."},{"key":"B23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijcard.2007.03.109","article-title":"Predictors of outcome in acute ischemic cerebrovascular syndromes: the GIFA study","volume":"125","author":"Tuttolomondo","year":"2008","journal-title":"Int J Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1194\/jlr.P030890","article-title":"Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions","volume":"53","author":"van Dijk","year":"2012","journal-title":"J Lipid Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1212\/WNL.58.4.653","article-title":"Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease","volume":"58","author":"Cerrato","year":"2002","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective","volume":"11","author":"Baumgart","year":"2015","journal-title":"Alzheimers Dement."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.736365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T04:57:49Z","timestamp":1638507469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.736365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":26,"alternative-id":["10.3389\/fneur.2021.736365"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.736365","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"article-number":"736365"}}